Holen Sie sich die Stockscreener-App
2.8001
0.26%
0.0027
Schlusskurs vom Vortag:
$2.8028
Offen:
$2.72
24-Stunden-Volumen:
34,698
Relative Volume:
1.46
Marktkapitalisierung:
$3.92M
Einnahmen:
$357.90K
Nettoeinkommen (Verlust:
$-11.06M
KGV:
-2.4999
EPS:
-1.1201
Netto-Cashflow:
$-11.90M
1W Leistung:
-30.34%
1M Leistung:
-31.13%
6M Leistung:
-39.44%
1J Leistung:
-91.05%
1-Tages-Spanne:
$2.72
$2.905
1-Wochen-Bereich:
$2.70
$3.576
52-Wochen-Spanne:
$2.70
$34.60
Biorestorative Therapies Inc Stock (BRTX) Company Profile
Firmenname
Biorestorative Therapies Inc
Sektor
Branche
Telefon
(631) 760-8100
Adresse
40 MARCUS DRIVE, MELVILLE
Compare BRTX vs VRTX, REGN, ARGX, MRNA, RVMD
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
BRTX
Biorestorative Therapies Inc
|
2.835 | 3.87M | 357.90K | -11.06M | -11.90M | -1.1201 |
VRTX
Vertex Pharmaceuticals Inc
|
521.29 | 134.06B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
803.98 | 83.43B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
1,005.12 | 63.00B | 4.16B | 1.29B | 734.26M | 19.58 |
MRNA
Moderna Inc
|
137.36 | 56.02B | 2.23B | -3.19B | -1.60B | -8.1462 |
RVMD
Revolution Medicines Inc
|
210.10 | 44.44B | 742.00K | -1.37B | -1.07B | -7.0731 |
Biorestorative Therapies Inc Aktie (BRTX) Neueste Nachrichten
BioRestorative Therapies, Inc. Earnings and Revenue – FWB:9OF0 - TradingView
BioRestorative Therapies Inc expected to post a loss of 12 cents a shareEarnings Preview - TradingView
Biorestorative Therapies To Carry Out 1-for-20 Reverse Stock Split On September 8th, 2026 - Moomoo
BioRestorative Therapies Announces Reverse Stock Split - Ortho Spine News
BioRestorative Therapies Announces 1-for-20 Reverse Stock Split - TipRanks
Biorestorative Therapies Announces Reverse Stock Split - TradingView
BioRestorative Therapies: Board Approves 1-For-20 Reverse Split >BRTX - Moomoo
BioRestorative Therapies Names New Interim CEO and CFO - Minichart
BioRestorative Therapies Inc (BRTX) Shareholding Pattern – Promoters, FIIs & DIIs - Value Research
BioRestorative Therapies Inc (BRTX) Key Financial Ratios – Valuation, Profitability & More - Value Research
BioRestorative Therapies Inc (BRTX) Peer Comparison – Compare with Others - Value Research
BRTX Q1 2026 Earnings: Narrower Net Loss Beats Estimates as Pipeline AdvancesQuarterly Earnings Report - vinanet.vn
BioRestorative Therapies Faces Nasdaq Delinquency Notice Risk - TipRanks
BioRestorative Therapies Received Notice of Noncompliance - TradingView
BioRestorative (BRTX) Chart: Slides 0.98% to $0.21 for the Current Session; Price Levels: Price Remains Between $0.20 Support and $0.22 Resistance in the Latest ReadingFibonacci Retracement - vinanet.vn
BioRestorative (BRTX) Move: Retreats 2.40% to $0.22 for the Current Session; Range Check: the Current Price Sits Inside the Supplied Technical Range in the Latest ReadingVolume Spike Alerts - vinanet.vn
BioRestorative Therapies Halts ExoCR and BioX Shipments - TipRanks
MSN Money - MSN
BioRestorative Therapies (NASDAQ:BRTX): Why Is Cell-Therapy Development And Manufacturing Readiness in Focus Today? - Kalkine Media
BioRestorative Therapies (NASDAQ:BRTX): Why Is Cell-Therapy Development And Funding in Focus Today? - Kalkine Media
BRTX Q2'26 Earnings: EPS estimate is (0.10) USD - TradingView
BioRestorative Therapies (BRTX) Holds Near $0.23 as Modest Gains Build on Thin VolumeFundamentals - dars.gov.et
Form 8K BioRestorative Therapies Inc For: 14 August By Investing.com - Investing.com Nigeria
BioRestorative Therapies suspends shipments of ExoCR and BioX products for review - Investing.com Australia
BioRestorative Therapies Delays Quarterly SEC Filing - TipRanks
Biorestorative Therapies Suspends All Orders, Shipments Of Exocr, Biox Biocosmeceutical Product Lines Effective Immediately, On Aug 7 - TradingView
BioRestorative Therapies (BRTX) delays Q2 10-Q amid losses and going-concern risk - Stock Titan
BioRestorative Therapies, Inc. Suspends All Orders And Shipments Of Biocosmeceutical Product Lines - marketscreener.com
BRTX Q2'26 Earnings: revenue estimate is 600.00K USD - TradingView
BRTX Q1 2026 Earnings: Narrower-Than-Expected Loss Delivers 41% EPS SurpriseRevenue Guidance Update - vinanet.vn
BioRestorative Therapies Inc (BRTX) Stock News Today - TradingKey
BioRestorative Therapies (BRTX) Edges Lower, Holds $0.20 Support as Price Action TightensFloat Adjusted Cap - dars.gov.et
BioRestorative Therapies (BRTX) investor Alta Partners reports 4.99% ownership cap - Stock Titan
BRTX Q1 2026 Earnings: Loss Beats Estimates by 41.18% While Shares Fall 9.22%Revenue Recognition Risk - vinanet.vn
BioRestorative Therapies (BRTX) reports director Esha Randhawa’s insider status - Stock Titan
BioRestorative Therapies Inc - TradingKey
BioRestorative Therapies Inc (BRTX) Balance Sheet - TradingKey
BioRestorative Therapies Inc (BRTX) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
BioRestorative Therapies Inc (BRTX) Valuation: PE, PB & Fair Value Analysis - TradingKey
BioRestorative Therapies Inc (BRTX) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
BioRestorative Therapies Inc (BRTX) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
BRTX|BioRestorative Therapies Inc|Price:0.219|Chg%:+0.018 - TradingKey
BioRestorative Therapies Inc (BRTX) Cash Flow - TradingKey
BioRestorative Therapies Inc (BRTX) Income Statement - tradingkey.com
BRTX|BioRestorative Therapies Inc|Price:0.270|Chg%:-0.007 - TradingKey
BioRestorative Therapies Inc (BRTX) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
BRTX|BioRestorative Therapies Inc|Price:0.282|Chg%:-0.008 - TradingKey
BRTX|BioRestorative Therapies Inc|Price:0.226|Chg%:+0.006 - TradingKey
BioRestorative Therapies (BRTX) Slides 7% – Testing Critical Support at $0.28Institutional Sentiment - vinanet.vn
BioRestorative Therapies, Inc. Revenue Breakdown – GETTEX:9OF - TradingView
BRTX Q1 2026 Earnings: Narrower Loss Exceeds Expectations Amid Pipeline ProgressEarnings Yield Analysis - vinanet.vn
Finanzdaten der Biorestorative Therapies Inc-Aktie (BRTX)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.69%
3.67%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):